Cepheid Q4 Revenues Increase 15 Percent
January 25, 2013
Cepheid Q4 Revenues Increase 15 Percent
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Spain's Stat-Diagnostica Aims to Market Near-patient IVD System in Europe, US in 2015
May 16, 2013 / PCR Insider - China's Zeesan Biotech Developing Portfolio of Melt Curve MDx Assays after SFDA Approves TB Tests
April 25, 2013 / PCR Insider - Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider - Cepheid's Q1 Revenues Increase 19 Percent
April 19, 2013 / GenomeWeb Daily News - Trovagene's Q4 Revenues, Loss Rise
April 2, 2013 / GenomeWeb Daily News